4//SEC Filing
Darvish Nissim 4
Accession 0001551986-20-000294
CIK 0001551986other
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 4:14 PM ET
Size
6.4 KB
Accession
0001551986-20-000294
Insider Transaction Report
Form 4
Darvish Nissim
Director10% Owner
Transactions
- Other
Common stock
2020-10-30+1,943,734→ 25,716,755 total(indirect: See footnote)
Footnotes (2)
- [F1]The shares of common stock of the Issuer reported on this Form 4 were released from escrow pursuant to Section 1.12 of that certain Agreement and Plan of Merger and Reorganization dated as of October 6, 2019 (as amended by Amendment No. 1 thereto, dated as of December 17, 2019). OrbiMed Israel Partners Limited Partnership's right to receive such escrowed shares became fixed and irrevocable on October 30, 2020, the six-month anniversary of the closing date of the merger.
- [F2]The Reporting Person is the designated representative of OrbiMed Israel GP Ltd. on the Issuer's Board of Directors. The reportable securities are owned directly by OrbiMed Israel Partners Limited Partnership ("OIP"). OrbiMed Israel BioFund GP Limited Partnership ("OrbiMed BioFund") is the general partner of OIP, and OrbiMed Israel GP Ltd. ("OrbiMed Israel") is the general partner of OrbiMed BioFund. OrbiMed Israel exercises this investment and voting power through a management committee comprised of Carl L. Gordon, Jonathan T. Silverstein, Nissim Darvish, Anat Naschitz and Erez Chimovits, each of whom disclaims beneficial ownership of the shares held by OIP for the purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
9 METERS BIOPHARMA, INC.
CIK 0001551986
Entity typeother
Related Parties
1- filerCIK 0001793602
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 7:00 PM ET
- Accepted
- Nov 3, 4:14 PM ET
- Size
- 6.4 KB